Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | ATP1A1 | P05023 | 2/20 | 0.35 |
| ▸ | ATP1B1 | P05026 | 2/20 | 0.35 |
| ▸ | ATP1A3 | P13637 | 2/20 | 0.35 |
| ▸ | ATP1B2 | P14415 | 2/20 | 0.35 |
| ▸ | ATP1A2 | P50993 | 2/20 | 0.35 |
| ▸ | ATP1B3 | P54709 | 2/20 | 0.35 |
| ▸ | FXYD2 | P54710 | 2/20 | 0.35 |
| ▸ | ATP1A4 | Q13733 | 2/20 | 0.35 |
| ▸ | GRIN1 | Q05586 | 4/20 | 0.34 |
| ▸ | GRIN2B | Q13224 | 4/20 | 0.34 |
| ▸ | NR1I3 | Q14994 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22856761 | 1.00 | SMN1; SMN2 (0.36) | SMN1; SMN2POLBATP1A1ATP1B1ATP1A3 | |
| SCHEMBL22856760 | 1.00 | SMN1; SMN2 (0.36) | SMN1; SMN2POLBATP1A1ATP1B1ATP1A3 | |
| SCHEMBL21886077 | 1.00 | SMN1; SMN2 (0.36) | SMN1; SMN2POLBATP1A1ATP1B1ATP1A3 | |
| SCHEMBL21886099 | 1.00 | SMN1; SMN2 (0.36) | SMN1; SMN2POLBATP1A1ATP1B1ATP1A3 | |
| SCHEMBL21206166 | 1.00 | SMN1; SMN2 (0.36) | SMN1; SMN2POLBATP1A1ATP1B1ATP1A3 | |
| SCHEMBL21886380 | 1.00 | SMN1; SMN2 (0.36) | SMN1; SMN2POLBATP1A1ATP1B1ATP1A3 | |
| SCHEMBL21886034 | 1.00 | SMN1; SMN2 (0.36) | SMN1; SMN2POLBATP1A1ATP1B1ATP1A3 | |
| SCHEMBL21886381 | 1.00 | SMN1; SMN2 (0.36) | SMN1; SMN2POLBATP1A1ATP1B1ATP1A3 | |
| SCHEMBL20528759 | 1.00 | SMN1; SMN2 (0.36) | SMN1; SMN2POLBATP1A1ATP1B1ATP1A3 | |
| SCHEMBL21886027 | 1.00 | SMN1; SMN2 (0.36) | SMN1; SMN2POLBATP1A1ATP1B1ATP1A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3606901-B1 | VETIVER ODORANT | FIRMENICH & CIE (CH) | 2021-08-11 | — | — | EP | claimed |
| US-10883066-B2 | Vetiver odorant | FIRMENICH SA (CH) | 2021-01-05 | — | — | US | claimed |
| US-20200109348-A1 | VETIVER ODORANT | FIRMENICH SA (CH) | 2020-04-09 | — | — | US | claimed |
| EP-3606901-A1 | VETIVER ODORANT | Firmenich SA (CH) | 2020-02-12 | — | — | EP | claimed |
| WO-2018185012-A1 | VETIVER ODORANT | FIRMENICH SA (CH) | 2018-10-11 | — | — | WO | claimed |
| EP-3606901-B1 | VETIVER ODORANT | FIRMENICH & CIE (CH) | 2021-08-11 | — | — | EP | disclosed |
| US-10883066-B2 | Vetiver odorant | FIRMENICH SA (CH) | 2021-01-05 | — | — | US | disclosed |
| US-20200109348-A1 | VETIVER ODORANT | FIRMENICH SA (CH) | 2020-04-09 | — | — | US | disclosed |
| EP-3606901-A1 | VETIVER ODORANT | Firmenich SA (CH) | 2020-02-12 | — | — | EP | disclosed |
| WO-2018185012-A1 | VETIVER ODORANT | FIRMENICH SA (CH) | 2018-10-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10883066-B2 | Vetiver odorant | VIPR1, VIPR2, BLVRB | SMN1; SMN2 2141/4885POLB 1557/4885ATP1A1 2997/4885 |
| US-20200109348-A1 | VETIVER ODORANT | VIPR1, VIPR2, BLVRB | SMN1; SMN2 2141/4885POLB 1557/4885ATP1A1 2997/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.